The objectives of this study were to compare the effects of two intravaginal devices (ID) containing the same dose (0.5 g)
of progesterone (P4) on subsequent ovarian response, embryo production and circulating P4 concentration profile in llamas (Lama glama) treated with equine chorionic gonadotropin (eCG) for ovarian superstimulation. Female llamas were randomly assigned (n = 10
llamas per group) to one of the following groups and treated (Day 0) with an ID containing 0.5 g of vegetal P4 to synchronize the emergence of a new follicular wave: i) DIB 0.5® and ii) Cronipres M15®. On Day 3 llamas were intramuscularly treated with 1000 IU of eCG. The IDs were removed on Day 7. Llamas were naturally mated
(Day 9) and treated with GnRH analogue to induce ovulation. A second mating was allowed 24 h later. Embryos were collected
between 7 and 8 days after the first mating. Blood samples were taken every day from Day 0 to Day 7 to measure circulating
P4 concentrations. The results indicated that DIB device maintained greater plasma P4 levels as compared to Cronipres until Day 2. However, the mean (± SD) number of corpora lutea and recovered embryos was not
affected (p < 0.05) by the type of ID (5.3 ± 2.6 vs 4.2 ± 2.2 and 3.5 ± 2.7 vs 2.6 ± 3.0 for DIB and Cronipres, respectively). In conclusion, both DIB and Cronipres devices can be successfully used to
synchronize the emergence of follicular wave prior to a single dose of eCG in superovulation protocol in llamas.

The South American camelids (SAC), also known as the New World Camelidae, are mainly reared in the High Andes having an important
economic and social role in countries such as Argentina, Bolivia, Chile, Peru and in recent years, Ecuador. Eighty-six per
cent of the world´s 3.5 million alpacas are found in Peru; likewise, the greatest percentage (>70%) of the world´s 3.1 million
llamas are found in Bolivia (Novoa, 1981). The greater population of guanacos is found in the Argentinean Patagonia, with an estimated number of 600,000 animals and
the vicuña population is distributed among all the aforementioned countries. In those countries, several programs for genetic
improvement (meat and fibre) have been undertaken based on assisted reproductive techniques.

Multiple ovulation and embryo transfer (MOET) allow the decrease of generational interval, optimization of mating programs
and increasing the reproductive potential from high genetic value females. In llama and alpaca, the MOET is more used than
artificial insemination due to poor results using frozen semen (Bravo et al., 2013). Ovarian superstimulation in SAC is performed under different general conditions: i) simulating a luteal phase by using
exogenous progesterone/progestogen, ii) during a luteal phase following ovulation induced by administration of hCG (human
chorionic gonadotropin), LH (luteinising hormone), GnRH (gonadotropin-releasing hormone) or iii) after ablation of all follicles
greater than 5 mm using transvaginal ultrasound-guided follicle aspiration. The simplest method to control follicular dynamics
and synchronization of the emergence of a new follicular development in llama is to use an intravaginal device (ID) (Chaves et al., 2002) or an ear implant containing progestogen (Bourke et al., 1995).

Progesterone may also have an important effect on oocyte quality decreasing the apoptosis rate of cumulus cells during maturation
(Salhab et al., 2011). On the other hand, a positive relationship between greater circulating levels of P4 during follicular growth and embryo quality have been recently described in dairy cows (Rivera et al., 2011). The precise effect of elevated P4 during the growth of the dominant follicle on the oocyte and embryo quality is unknown (Fair & Lonergan, 2012) but it may be related to reduced exposure of the developing oocyte to LH, avoiding its premature maturation (Cerri et al., 2011).

In Argentina, different kinds of IDs containing different amounts of P4 for use in cattle have been developed by pharmaceutical industry in the last 10 years and are exported to all South America,
especially to the Andean countries where the SAC are raised. Moreover, IDs containing low dose (≤ 0.5 g) of P4 should preferably be used to reduce environmental pollution after use in animals.

These IDs, that contain the same P4 dose, vary in shape and surface contact area, variations which could have an effect on the synchronization obtained. Thus,
differences in physical characteristics among IDs produce different plasma P4 concentrations in cattle (Rathbone et al., 1998; 2002). In a recent study, van Werven et al. (2013) found that PRID® produced significantly greater circulating P4 concentration compared to CIDR® and suggested that both levels of P4 content and differences in shape and contact surface area might contribute to circulating P4 concentrations.

Therefore, the objectives of the present work were to compare the effects of two commercially available and commonly used
IDs containing low dose of P4 and varying in their structure and shape on subsequent bioavalability in blood plasma, ovarian response and embryo yield
in llamas treated with eCG for ovarian superstimulation.

This work was carried out at Abra Pampa Experimental Station of the National Institute of Agricultural Technology (INTA),
located in the province of Jujuy (22º 49´S, 65º 47´W; 3,483 m above sea level) during non-breeding season. Animals weighed
102.3 ± 7.8 kg, with a body condition score of 4.6 ± 1.1 (1 = emaciated to 9 = obese; Richards et al., 1986) determined by palpation. Llamas were selected (n = 20 from a group of 60) and randomly allocated in equal numbers (n = 10)
to one of two groups to be treated (Day 0) with an intravaginal device (i) DIB 0.5® (Syntex, Argentina) (DIB group) or (ii) Cronipres M15® (Biogenesis-Bago, Argentina) (Cronipres group) and both IDs containing 0.5 g of progesterone. Each ID was removed seven days
later. Ovarian follicular development was stimulated by intramuscular administration of 1000 IU of eCG (Novormon 5000®, Syntex, Argentina) (Day 3). Llamas were naturally mated (Day 9) with males of proven fertility and immediately treated with
100 µg of GnRH analogue of gonadorelin (Gonasyn GDR®, Syntex, Argentina) as an additional stimulus to induce ovulation. A second mating was allowed 24 h later.

Embryo recovery from the donor females was performed non-surgically 7 days after the first mating as described previously
(Aller et al., 2002). Briefly, each female was sedated with 10 mg acepromazine (Acedan®, Holliday, Argentina) and caudal epidural anaesthesia
with 3 mL of 2% lidocaine hydrochloride was induced before uterine flushing. Each uterine horn was flushed using 14-Fr Rusch
two-way catheter and 250 mL of Ringer lactate supplemented with 1% heat-inactivated cow serum. The flushing medium was filtered
(EmCon, Minitüb, Germany) and searching embryos was performed using a stereomicroscope at magnification x40. The recovered
embryos were transferred to holding medium (Syngro holding medium®, Bioniche Animal Health, Canada) and kept at room temperature
and classified according to IETS standards for cattle embryos (IETS Manual, 1998). After embryo collection, ovarian responses in the donor females were evaluated by transrectal ultrasonography using a real
time scanner with a 5-MHz linear array transducer (Honda HS 101V, Japan).

Blood samples were collected on Days 0, 1, 2, 3, 4, 7 and 9 by jugular venipuncture into tubes containing sodium heparin (Fada
Pharma, Argentina) and immediately centrifuged at 1500 xg for 20 min. The blood plasma was stored at –20ºC until hormone analyses. Concentrations of P4 were measured by a radioimmunoassay commercial kit (Siemens Medical Solutions Diagnostics, Los Angeles, CA, USA) for use
in bovine and validated for llama (Aba et al., 1999). Samples were evaluated in duplicate and all samples were analyzed in a single assay. The intra- assay coefficient of variation
was < 9%, for concentrations between 0.1 and 40.0 ng/mL. The estimated sensitivity of this method was 0.01 ng/mL.

Data analyses were performed using SAS (1989). Number of unovulated follicles ≥ 7 mm, number of corpora lutea (CL) and number of recovered embryos were compared between
groups using one-way ANOVA. Plasma P4 concentration was analyzed by ANOVA for repeated measures (PROC MIXED); the model included the effects of treatment, day
and treatment by day interaction, with day as a repeated effect. Proportional data were compared by Chi square test. Correlation
coefficients (Pearson correlation) between number of CL and number of recovered embryos were calculated (Steel & Torrie, 1980). Probability of p < 0.05 was considered to be statistically significant.

On Day 9, all llamas were sexually receptive and successfully mated. After device removal, a slight vaginitis was observed;
however, the fertility was not compromised because ejaculation is deep intracornual in this species. The mean number of unovulated
follicles ≥ 7 mm, CL and recovered embryos were not affected (p > 0.05) by treatment (Table 1). The recovery rates (total number of recovered embryos relative to the total number of CL) were 66.0 (35/53) and 61.9% (26/42)
for DIB and Cronipres groups respectively (p > 0.05). All recovered embryos, regardless of group, were graded as excellent quality hatched blastocysts. Embryos could
not be collected from 4 of the 20 animals (two animals of each group). Approximately 20% of the animals did not respond to
the superovulatory treatment. Significant positive correlations between number of CL and number of recovered embryos for DIB
and Cronipres groups were detected (r = 0.68, p = 0.02 and r = 0.80, p = 0.005, respectively).

The main finding from this experiment was that both intravaginal devices (DIB and Cronipres) containing low dose of progesterone
used during superovulation treatment produced a similar ovarian response and number of recovered embryos in llamas.

Several research groups have looked for possible associations between endogenous (natural luteal phase) or exogenous progesterone
priming (treatment used to control the ovarian follicular dynamics) and the response to superovulation as a potential explanation
for some of the persistent variability in superovulation seen between animals (Kanitz et al., 2002; Mapletoft et al., 2002). In this study, the aim was to investigate any differences in quantity and quality of embryos produced in response to either
DIB or Cronipres progesterone ID combined with eCG for ovarian superstimulation in llamas.

The use of progesterone to synchronize the follicular wave emergence obviates the need to know the specific follicular stage
when starting the superovulatory treatment and this treatment should be initiated near the time of follicular wave emergence
to produce the maximal superovulatory response (Adams et al., 1994). In llamas, Aller et al. (2010) observed that the follicular wave emergence occurred approximately on Day 4 (± one day) after medroxiprogesterone acetate
intravaginal sponge insertion. Therefore, in the present study the eCG treatment for ovarian stimulation was administered
on Day 3 after ID insertion.

Superovulatory treatment can be initiated in natural luteal phase, but require the use of ultrasonography to detect the growing
dominant follicle and then to induce ovulation with human chorionic gonadotrophin (San Martin et al., 1968) or luteinizing hormone (Fernandez-Baca et al., 1970). Therefore, we chose exogenous progesterone because this hormone allows regulate the ovarian function indirectly through
LH secretion, rather than by direct actions on the ovaries. The P4 device is very simple to apply in field conditions to control the ovarian follicular dynamics and predicts the emergence
of a new follicular wave and thus to start the ovarian superstimulatory treatment without the use of ultrasound.

In the present study the number of CL and embryos recovered per llama did not differ between DIB and Cronipres group. Huanca et al. (2009) using progestin-realising vaginal sponges obtained a greater number of CL (8.6) but the number of recovered embryos (3.5)
was similar to our study. Additionally, Carretero et al. (2010), who used daily intramuscular administration of progesterone during five days to inhibit follicular growth obtained 2.9 embryos
per female. Progestogen implants inserted over a period of 7 days combined with 1000 IU of eCG on Day 5 yielded a low embryo
recovery (1.3 embryos per donor female); however, the same protocol using CIDR® improved the embryo recovery (2.0 embryos)
(Bourke et al., 1992).

The recovery rates for DIB and Cronipres groups were significantly higher than the recovery rates obtained from other small-scale
studies in llama (Correa et al., 1997, 34.5%; Ratto et al., 1997, 16.9%). On the other hand, in a very large data set collected recently by Vaughan et al. (2013) from commercial alpaca embryo transfer records the recovery rate was 38.8% (4188 embryos/10796 ovulations).

The effect of elevated progesterone during follicular growth has been linked to improved embryo quality (Lonergan, 2011). Additionally, Rivera et al. (2011) showed that high P4 during ovarian superstimulation treatment of lactating dairy cows increased the quality of embryos collected on Day 7 after
estrus. In the present study, all recovered embryos were hatched blastocysts graded as excellent quality. The associations
between number of CL and recovered embryos for DIB and Cronipres groups were similar to that observed by Vaughan et al. (2013) in alpacas (r = 0.54). However, no significant correlation (r = 0.12) was detected by Aller et al. (2010), possibly as consequence of the high number of ovarian follicles (12.4) induced by the superovulatory treatment; therefore,
the ovarian bursa can be displaced leading to a loss of oocytes into the abdominal cavity and a low number of recovered embryos.

Plasma P4 concentrations rose quickly after ID insertion (Day 0) with peak concentration attained on Day 1. Significant differences
of circulating P4 concentrations between DIB and Cronipres devices were observed at this day. Following 48 h after device removal, P4 concentrations were not significantly different to pre-treatment concentrations. Treatments with an intravaginal CIDR® device
containing 0.33 g of progesterone (Chaves et al., 2002) and medroxiprogesterone acetate-vaginal sponge (Aba et al., 1999; Huanca et al., 2009) were successfully used to control ovarian follicular dynamics. Progesterone concentrations similar to the one observed in
our study was described by Chaves et al. (2002) where a rapid increase was observed at Day 1 (~10 ng/mL) and sharply decreased until Day 4 (2 ng/mL).

The two types of ID used in the present study have the same P4 content (0.5 g), therefore differences in contact surface area (DIB ~95 cm2vs Cronipres ~60 cm2) might contribute to differences in plasma P4 concentrations. Additionally, because the shape of the two IDs differ greatly (DIB = V-shape vs. Cronipres = double L-like with three hood containing progesterone) it may influencing the surface area of the devices in
direct contact with the vagina wall since the rate of diffusion of P4 from ID to bloodstream could be considered similar, because the two IDs have the same type of outer layer material (inert
silicone).

The results supported the hypothesis that the shape and contact surface area with the vagina wall of two ID (DIB and Cronipres)
containing the same P4 levels have effect on the plasma P4 concentrations. In spite of the differences in physical characteristic and the plasma P4 concentrations observed between devices, the ovarian superstimulation protocols using eCG combined with DIB or Cronipres
were equally effective to induce a good superovulatory response and embryo production.